Eledon Pharmaceuticals Correlations
ELDN Stock | USD 3.55 0.06 1.66% |
The current 90-days correlation between Eledon Pharmaceuticals and Terns Pharmaceuticals is 0.5 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Eledon Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Eledon Pharmaceuticals and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Eledon |
Moving together with Eledon Stock
0.61 | CDIOW | Cardio Diagnostics | PairCorr |
0.73 | WMT | Walmart | PairCorr |
0.64 | BA | Boeing | PairCorr |
0.8 | HD | Home Depot | PairCorr |
0.82 | DIS | Walt Disney | PairCorr |
0.62 | MSFT | Microsoft Aggressive Push | PairCorr |
Moving against Eledon Stock
0.4 | LUCD | Lucid Diagnostics | PairCorr |
0.53 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
0.49 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.45 | CVX | Chevron Corp | PairCorr |
0.38 | T | ATT Inc Sell-off Trend | PairCorr |
0.31 | INTC | Intel Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Eledon Stock performing well and Eledon Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eledon Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INZY | 4.12 | (1.40) | 0.00 | (0.80) | 0.00 | 6.82 | 36.29 | |||
DAWN | 2.88 | (0.52) | 0.00 | (0.61) | 0.00 | 6.36 | 22.86 | |||
TERN | 3.07 | (0.93) | 0.00 | (0.94) | 0.00 | 5.03 | 19.13 | |||
HOOK | 3.63 | (0.76) | 0.00 | (8.73) | 0.00 | 7.00 | 32.80 | |||
XFOR | 6.28 | (0.68) | 0.00 | (2.46) | 0.00 | 10.87 | 68.45 | |||
ABOS | 3.02 | (0.59) | 0.00 | (0.49) | 0.00 | 6.57 | 19.77 | |||
AMLX | 3.67 | 0.00 | 0.00 | (0.04) | 0.00 | 7.20 | 21.45 | |||
MREO | 2.63 | (0.41) | 0.00 | (0.56) | 0.00 | 6.16 | 20.77 |
Eledon Pharmaceuticals Corporate Management
Marina Escudero | VP Operations | Profile | |
Gregory Flesher | Consultant | Profile | |
Bryan JD | Corporate Counsel | Profile | |
John Herberger | Vice Operations | Profile | |
Paul Little | Chief Officer | Profile | |
David Hovland | Chief Officer | Profile |